Although common in osteosarcoma across age groups, TP53 abnormalities appear more common in children younger than 18, as whole genome sequencing studies inclusive of patients over 18 report a 40–75% frequency of TP53 pathway mutations [55,56]. The gene discussed is TP53; the disease is osteosarcoma.